Global Antimicrobial Susceptibility Testing Market 2025 | Major Players-Alifax Holding S.p.A., Merck & amp; Co. Inc., Bioanalyse Tibbi Malz. Singing. and Tic. Ltd. Sti., Creative Diagnostics., Genefluidics Inc., Conda

Global Antimicrobial Susceptibility Testing Market

Global Antimicrobial Susceptibility Testing Market report offers all the company profiles of the leading players and brands. Global Antimicrobial Susceptibility Testing Market report is an in-depth study of the industry that explains the definition of the market, classifications, applications, commitments, and global industry trends. This report gives the opportunity to surpass the competition. The drivers and restrictions of the market have been explained with the help of the SWOT analysis and the Porter Five Forces tool. The Global Antimicrobial Susceptibility Testing Market is divided into products, applications, end users and regions. The analysis of the historical year and the base year 2017 in 2016 shows that new highs will be achieved in the 2018-2025 Global Antimicrobial Susceptibility Testing Market. The best players and brands on the market make calculated movements such as product launches, research, joint ventures, mergers, and acquisitions.

Global Antimicrobial Susceptibility Testing Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Major Players: Global Antimicrobial Susceptibility Testing Market

Some of the prominent participants operating in this market are- BioMérieux SA, Thermo Fisher Scientific, BD,  Bio-Rad Laboratories, Inc.,  HiMedia Laboratories., Liofilchem S.r.l., Accelerate Diagnostics, Inc., Alifax Holding S.p.A., Merck & Co., Inc., Bioanalyse Tibbi Malz. Singing. and Tic. Ltd. Sti., Creative Diagnostics., Genefluidics, Inc..,   Conda,  Zhuhai DL Biotech. Co. Ltd., among others.

Get A Free Sample Report Now @

Products of the Report:

  1. Historical and current market size and projection up to 2025.
  2. Competitive landscape
  3. Potential and niche segments/regions exhibiting promising growth
  4. The study provides an in-depth analysis of the Global Antimicrobial Susceptibility Testing Market and current & future trends to elucidate imminent investment pockets.
  5. Analyze and forecast Global Antimicrobial Susceptibility Testing Market on the basis of type, function, and application.
  6. Company profiling of key players which includes business operations, product and services, geographic presence, recent developments, and key financial analysis.

Segmentation: Global Antimicrobial Susceptibility Testing Market

Global Antimicrobial Susceptibility Testing Market By Product(Automated Laboratory Instruments, Susceptibility Testing Disks),By Methods(Dilution, Disk Diffusion, E-test & others),By Type(Antibacterial Testing, Antifungal Testing),By Application(Clinical Diagnostics, Epidemiology),By End User, By Geography(North America, South America, Europe, Asia-Pacific, Middle East And Africa)– Industry Trends and Forecast to 2025

Drivers: Global Antimicrobial Susceptibility Testing Market

Prominent factors driving the growth of this market consist of an increase in the number of infectious diseases,  technological advancements in antimicrobial susceptibility methods, increased funding, research grants, and public-private investments. Other factor propelling market growth includes the emergence of multidrug resistance due to drug abuse.

Increase in number of infectious diseases:

Infectious diseases are disorders mainly caused by microorganisms such as viruses, bacteria fungi or parasites. Many microorganisms live in and on our bodies. They are normally harmless or even helpful, but under certain conditions in which some organisms may cause disease.

Infectious diseases can be contagious or non-contagious. Some infectious diseases can be transferred from person to person. Some are passed by bites from insects or animals. And others are acquired by ingesting contaminated water or food or being exposed to organisms in the environment.

Many companies offers manual as well as automated devices for susceptibility testing of microbes such as, Vitek-2 (bioMérieux, France), Phoenix (BD, U.S.), Microscan (Beckman Coulter, Brea, CA) are also available for high- throughput AST in laboratories with large workloads. These systems are based on automation of the broth dilution method for MIC testing, and in some cases they extrapolate the MIC values from growth curves recorded at different antimicrobial concentrations using dedicated algorithms. Whichever the method, the information is then translated into a susceptibility category including susceptible, resistant, and intermediate or susceptible-dose dependent based on the comparison of AST results with reference values of MIC or inhibitory zone diameters.

Increased funding, research grants, and public-private investments:

Antimicrobial resistance to different antibiotic is a serious concern for Scientist.  Government is giving large amount of funds to prestigious institutes and organizations to carry out high end research to prevent further crisis.

In April 2016 , according to article published in National Center for Biotechnology Information, it was     identified 1,234 publicly funded antibacterial resistance projects with a total investment of  USD 1,112.27 million across 19 Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) countries and European Union (EU)-level organizations  including Directorate General for Research and Innovation [DG Research], European Centre for Disease Prevention and Control [ECDC], Directorate General for Health and Consumer Affairs [DG-SANCO], and Innovative Medicines Initiative related to antibacterial resistance from 2007 to 2013 to have the evidence base to influence future work.

For Instance, 22 research-based biopharmaceutical companies including AstraZenica (U.K) GlaxoSmithKline (U.K) and Merck (U.S) invested more than USD 2 billion in research and development to counter antimicrobial resistance in 2016. According to a survey released January 2018  potentially upending widespread perceptions that the private sector is trailing institutional donors in tackling anti-microbial resistance.

Available a Free Report TOC @

Global Antimicrobial Susceptibility Testing Market : Report Synopsis

  1. To analyze the market size of the market and infer the key trends from it.
  2. Industry Chain Suppliers of Global Antimicrobial Susceptibility Testing Market with Contact Information
  3. The key findings and recommendations highlight crucial progressive industry trends in the Global Antimicrobial Susceptibility Testing Market, thereby allowing players to develop effective long term strategies
  4. To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the Global Antimicrobial Susceptibility Testing Market.
  5. Comprehensive quantitative analysis of the industry is provided for the period of 2018-2025 to assist stakeholders to capitalize on the prevailing market opportunities.

Read More Detailed and Analyzed Content on our Report Page @ Global Antimicrobial Susceptibility Testing Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us-

Data Bridge Market Research

US: +1-888-387-2818


Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *